^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

angiozyme (ABI-873)

i
Other names: ABI-873, RPI.4610
Associations
News
Trials
Company:
Actis Biologics
Drug class:
VEGFR-1 antagonist
Associations
News
Trials